← Back to Search

Behavioral Intervention for Laryngeal Cancer

N/A

Waitlist Available

Research Sponsored by Thomas Jefferson University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 12 weeks after physical activity promotion

Awards & highlights

Study Summary

This trial is testing whether a physical activity program prescribed by a physical therapist can help head and neck cancer patients who are undergoing cancer treatment. The goal is to help patients reduce fatigue, improve mood, increase physical performance, and decrease joint pain.

Eligible Conditions

Laryngeal Cancer
Lung Cancer
Head and Neck Cancers
Hypopharyngeal Cancer
Maxillary Sinus Cancer
Oral Cancers
Paranasal Sinus Cancer
Sinonasal Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 12 weeks after physical activity promotion

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 12 weeks after physical activity promotion

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks after physical activity promotion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Fitbit-recorded average active minutes (moderate and/or intensive) per day, each day

Change in Fitbit-recorded average steps (moderate and/or intensive) per day, each day

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (exercise training, behavior modification)Experimental Treatment6 Interventions

Beginning 1 week prior to start of intervention, patients receive a Fitbit to monitor physical activity for 13 weeks. Patients receive consultation and personalized exercise prescription from a physical therapist at baseline, and attend exercise training sessions with a physical therapist during weeks 1, 3, 6, 9, and 12. Patients also attend behavior modification sessions with a behavioral therapist that focus on goal setting and healthy behavior changes during weeks 2, 4, 5, 7, 8, 10, and 11.

Group II: Arm II (Fitbit, consultation)Active Control4 Interventions

Patients receive a Fitbit to monitor physical activity for 12 weeks. Patients also receive consultation from a physical therapist to assess physical performance at weeks 1, 6, and 12.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Behavioral Intervention

2021

Completed Phase 4

~3740

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor

445 Previous Clinical Trials

145,702 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots for eligible participants in this current research?

"Affirmative. Per the details hosted on clinicaltrials.gov, this trial is actively enrolling patients as of June 8th 2021. This study was initially posted on March 28th and it seeks 20 participants across a single site."

Answered by AI

How many participants are receiving treatment as part of this research?

"Affirmative. As found on clinicaltrials.gov, the trial is currently signing up participants and was first published on March 28th 2021 with its latest update occurring June 8th 2021. The goal of this research project is to recruit 20 people from a single medical facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment

2021. "Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04788264.